Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001193805-18-000697
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-16 17:00:28
Reporting Period:
2018-05-14
Accepted Time:
2018-05-16 17:00:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1368514 Adma Biologics Inc. ADMA Biological Products, (No Disgnostic Substances) (2836) 562590442
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1708960 Biotest Pharmaceuticals Corp 901 Yamato Road, Suite 101
Boca Raton FL 33431
No No Yes No
1709152 Ag Biotest Landsteinerstr. 5
Dreieich 2M 63303
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Non-Voting Common Stock Disposition 2018-05-14 8,591,160 $0.00 0 No 4 S Indirect By Biotest Pharmaceuticals Corporation
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Biotest Pharmaceuticals Corporation
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 10,109,534 Indirect By Biotest Pharmaceuticals Corporation
Footnotes
  1. On May 14, 2018, pursuant to a Share Transfer, Amendment and Release Agreement, by and among, among other parties, the issuer, Biotest Pharmaceuticals Corporation ("BPC") and Biotest AG, BPC transferred to the issuer, for no cash consideration, 8,591,160 shares of the issuer's non-voting common stock previously issued to BPC in June 2017 and representing 100% of the issuer's then-issued and outstanding non-voting common stock.
  2. The shares were owned directly by BPC, a ten percent owner of the issuer and a wholly owned subsidiary of Biotest AG, and indirectly by Biotest AG.
  3. The shares are owned directly by BPC, a ten percent owner of the issuer and a wholly owned subsidiary of Biotest AG, and indirectly by Biotest AG.